GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolutionary Genomics Inc (OTCPK:FNAM) » Definitions » E10

Evolutionary Genomics (Evolutionary Genomics) E10 : $-1.76 (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Evolutionary Genomics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evolutionary Genomics's adjusted earnings per share data for the three months ended in Dec. 2022 was $-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.76 for the trailing ten years ended in Dec. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-16), Evolutionary Genomics's current stock price is $0.45. Evolutionary Genomics's E10 for the quarter that ended in Dec. 2022 was $-1.76. Evolutionary Genomics's Shiller PE Ratio of today is .


Evolutionary Genomics E10 Historical Data

The historical data trend for Evolutionary Genomics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolutionary Genomics E10 Chart

Evolutionary Genomics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -1.89 -1.75 -1.77 -1.76

Evolutionary Genomics Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.77 -1.78 -1.79 -1.76 -1.76

Competitive Comparison of Evolutionary Genomics's E10

For the Biotechnology subindustry, Evolutionary Genomics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolutionary Genomics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolutionary Genomics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evolutionary Genomics's Shiller PE Ratio falls into.



Evolutionary Genomics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Evolutionary Genomics's adjusted earnings per share data for the three months ended in Dec. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=-0.06/125.2218*125.2218
=-0.060

Current CPI (Dec. 2022) = 125.2218.

Evolutionary Genomics Quarterly Data

per share eps CPI Adj_EPS
201303 0.000 98.209 0.000
201306 0.000 98.518 0.000
201309 -0.027 98.790 -0.034
201312 -0.027 98.326 -0.034
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 -0.071 100.428 -0.089
201412 -10.621 99.070 -13.425
201503 0.020 99.621 0.025
201506 -0.140 100.684 -0.174
201509 -0.040 100.392 -0.050
201512 0.100 99.792 0.125
201603 -0.050 100.470 -0.062
201606 -0.060 101.688 -0.074
201609 -0.060 101.861 -0.074
201612 -0.060 101.863 -0.074
201703 -0.090 102.862 -0.110
201706 -0.060 103.349 -0.073
201709 -0.050 104.136 -0.060
201712 0.080 104.011 0.096
201803 -0.060 105.290 -0.071
201806 -0.070 106.317 -0.082
201809 -0.060 106.507 -0.071
201812 -0.040 105.998 -0.047
201903 -0.040 107.251 -0.047
201906 -0.040 108.070 -0.046
201909 -0.040 108.329 -0.046
201912 -0.050 108.420 -0.058
202003 -0.050 108.902 -0.057
202006 -0.060 108.767 -0.069
202009 0.080 109.815 0.091
202012 -0.300 109.897 -0.342
202103 -0.100 111.754 -0.112
202106 -0.110 114.631 -0.120
202109 -0.190 115.734 -0.206
202112 -0.120 117.630 -0.128
202203 -0.100 121.301 -0.103
202206 -0.090 125.017 -0.090
202209 -0.090 125.227 -0.090
202212 -0.060 125.222 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Evolutionary Genomics  (OTCPK:FNAM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Evolutionary Genomics E10 Related Terms

Thank you for viewing the detailed overview of Evolutionary Genomics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolutionary Genomics (Evolutionary Genomics) Business Description

Traded in Other Exchanges
N/A
Address
4220 Morning Star Drive, Castle Rock, CO, USA, 80108
Evolutionary Genomics Inc is involved in the development of a technology platform, the Adapted Traits Platform (ATP), to identify commercially valuable genes that control important traits in animals and plants. It uses the ATP to identify genes to improve crop plant traits such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. The company's platform identifies key genes that have changed successfully to impart new or improved traits. Its primary source of revenue had been contract services revenue for research performed by it on behalf of other commercial entities and grant income received from governmental agencies, industry associations and grant-making foundations for research performed.
Executives
Steve B Warnecke director, 10 percent owner, officer: Chairman, CEO C/O TARGETED MEDICAL PHARMA, INC., 2980 BEVERLY GLEN CIRCLE, SUITE 301, LOS ANGELES CA 90077
Virginia P. Orndorff director 4580 AUGUSTA DR., BROOMFIELD CO 80023
Walter Messier officer: Secretary / Treasurer 1586 GOSHAWK DRIVE, LONGMONT CO 80504
Mark Virgil Boggess director 7857 E OAKBROOK CIR, MADISON WI 53717
Sanford Schwartz director, 10 percent owner 5353 MANHATTAN CIRCLE, STE 101, BOULDER CO 80303
Michael Friess director, 10 percent owner, officer: President/CEO 5353 MANHATTAN CIRCLE, STE 101, BOULDER CO 80303
Chloe M Divita director, officer: Secretary/Treasurer/CFO 5353 MANHATTAN CIRCLE, SUITE 101, BOULDER CO 80303

Evolutionary Genomics (Evolutionary Genomics) Headlines

No Headlines